ARCHIVES

ACS Challenged To Clarify Position On FDA Reform

This article is from The Cancer Letter archive.

Vol. 22 No. 09 | March 1, 1996

Download PDF Visit The Full Archive

Related Articles

Genomic Health Presents Meta-Analyses of Oncotype DX

January 28, 2011

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

Clearinghouse Insists On New Dichlorvos Test; CSWG Disagrees

March 24, 1978